Comparison of Insulins Aspart and Lispro in Insulin Pumps

Completed · Phase 4

Conditions studied: Type 1 Diabetes Mellitus

In brief

The purpose of the study is to compare the glycemic control between insulins aspart and lispro 48 to 100 hours after pump infusion line change in subjects with type 1 using diabetes using an insulin pump.

Key facts

Study ID

NCT00461331

Run by

Tulane University Health Sciences Center

People needed

20

Starts

2004-10-01

Expected to finish

2008-08-01

Last updated by the study team

2021-01-08

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 1 Diabetes treated with a pump for at least 3 months

You may not qualify if…

• Pregnancy
• Plasma Creatinine > 1.2 mg/dl
• Inability to give informed consent
• HbA1c > 8%
• Known or suspected hypersensitivity to trial drugs or any of their components

Where it is running

• Clinical Translational Unit - Tulane School of Medicine — New Orleans, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.